What are the best eyedrops (artificial tears) for a patient experiencing eye dryness, irritation, and burning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Eyedrops for Eye Dryness, Irritation, and Burning

Start with preservative-free artificial tears containing polyethylene glycol or hyaluronic acid/hyaluronate, applied at least twice daily and increased up to hourly based on symptom severity. 1

First-Line Treatment: Artificial Tears Selection

Preservative-free formulations are mandatory when using drops more than 4 times daily to avoid ocular surface toxicity. 1, 2, 3

Most Effective Formulations (in order of evidence strength):

  • Polyethylene glycol-based artificial tears are more effective than carboxymethylcellulose or hydroxypropyl methylcellulose for symptom relief. 4

  • Combination formulations (containing multiple active ingredients) are more effective than single-ingredient artificial tears. 4

  • Methylcellulose-based or hyaluronic acid/hyaluronate-based tears are recommended as first-line polymeric lubricants. 1, 3

  • Carboxymethylcellulose (0.5-1%) and carmellose sodium are acceptable alternative options. 1

Application Strategy by Time of Day:

  • Use liquid drops during daytime for immediate relief. 1, 3

  • Apply gels for longer-lasting effect when extended protection is needed. 1, 3

  • Use ointments overnight for nocturnal symptoms, followed by morning lid hygiene to prevent blepharitis. 1, 3

When Artificial Tears Alone Are Insufficient

If symptoms persist after 2-4 weeks of optimized artificial tear therapy (used at least 4 times daily), advance to anti-inflammatory agents. 1, 2, 3

Second-Line Options:

  • Add topical cyclosporine 0.05% (Restasis) twice daily for moderate dry eye with demonstrated success rates of 74% in mild, 72% in moderate, and 67% in severe dry eye. 1, 2

  • Lifitegrast 5% (Xiidra) twice daily is an alternative second-line agent that blocks LFA-1/ICAM-1 interaction and improves both signs and symptoms. 1, 5

  • Short-term topical corticosteroids (2-4 weeks maximum) can be used for acute exacerbations to decrease irritation and corneal staining, but never extend beyond 4 weeks due to risks of infection, increased intraocular pressure, and cataract formation. 1, 2

Special Considerations for Underlying Conditions

Always treat concurrent blepharitis or meibomian gland dysfunction with warm compresses (5-10 minutes twice daily) and gentle lid massage, as failing to address these conditions will cause treatment failure regardless of artificial tear use. 1, 2, 3

  • Use lipid-containing eye drops specifically if meibomian gland dysfunction is present to supplement the deficient lipid layer. 1, 3

Critical Environmental Modifications

  • Eliminate all cigarette smoke exposure completely, as smoking adversely affects the tear film lipid layer. 1, 2, 3

  • Humidify ambient air and use side shields on spectacles to minimize air draft exposure. 1, 2, 3

  • Lower computer screens below eye level and schedule breaks every 20 minutes to increase full blinking during screen time. 1, 2, 3

Common Pitfalls to Avoid

  • Never use preserved artificial tears more than 4 times daily as this causes ocular surface toxicity; switch to preservative-free formulations at this frequency. 1, 2, 3

  • Avoid or minimize oral antihistamines in patients with dry eye as they exacerbate symptoms. 1

  • Never extend topical corticosteroid use beyond 4 weeks due to serious complications including infections, increased IOP, and cataract development. 2

  • Do not use topical corticosteroids in patients with glaucoma or ocular hypertension due to risk of IOP elevation. 2

When to Refer to Ophthalmology

Refer immediately if any of the following occur: 2, 3

  • Moderate or severe eye pain
  • Lack of response after 2-4 weeks of optimized treatment
  • Corneal infiltration or ulceration
  • Vision loss or visual disturbances
  • Need for steroids beyond 4 weeks

References

Guideline

Dry Eye Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Dry Eyes with Steroid Eye Drops

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Artificial Tears for Diabetic Patients with Dry Eye

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Artificial Tears: A Systematic Review.

Clinical optometry, 2023

Related Questions

What are the treatment options for dry eyes?
What are the treatments for eye dryness and redness?
What is the best over-the-counter (OTC) medication for dry eye syndrome?
What are the treatment options for dry eyes?
What are the guidelines for long-term use of Refresh Tears (artificial tears) for dry eye syndrome?
Is cardiac catheterization medically necessary for a patient with aortic root dilation, atrial fibrillation (AFib), shortness of breath (SOB), and chest discomfort, who also has a history of hypertension, large B-cell lymphoma, and gastroesophageal reflux disease (GERD), with echocardiogram findings of mild left ventricular hypertrophy, mildly dilated left atrium, and mild aortic regurgitation?
What causes new-onset diabetes in individuals with no prior history of the disease?
At what age should an individual undergo a fit test for respirator use, considering their medical history and potential respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD)?
What causes post-transplant diabetes in patients who have undergone organ transplants, such as kidney, liver, or heart transplants, and have risk factors like obesity, physical inactivity, and a family history of diabetes?
What is the recommended approach for cardiopulmonary evaluation and risk stratification in a surgical patient with potential cardiopulmonary risk factors?
What is the role of Ursodeoxycholic acid (UDCA) in treating other forms of cholestatic hepatitis beyond primary biliary cholangitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.